Swedish Orphan Biovitrum AB (publ) (BIOVF)

BIOVF Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	15,862	12,444	9,959	9,119	6,204	6,120
Market Cap Growth	49.75%	24.95%	9.22%	46.98%	1.37%	2.62%
Enterprise Value	17,038	13,806	11,522	11,146	7,153	7,393
Last Close Price	37.00	35.25	27.66	26.25	21.15	20.39
PE Ratio	305.87	239.96	28.37	38.07	24.52	20.66
PS Ratio	5.18	4.06	4.24	4.14	3.44	3.56
PB Ratio	3.88	3.04	2.74	2.71	2.44	2.38
P/FCF Ratio	17.15	13.46	15.27	25.50	14.36	10.21
P/OCF Ratio	17.07	13.39	14.92	20.52	14.13	10.12
EV/Sales Ratio	5.37	4.51	4.90	5.07	3.97	4.31
EV/EBITDA Ratio	13.20	11.08	13.74	14.87	11.31	11.93
EV/EBIT Ratio	18.94	15.90	21.90	24.09	16.50	17.62
EV/FCF Ratio	18.42	14.93	17.67	31.16	16.56	12.33
Debt / Equity Ratio	0.31	0.31	0.42	0.61	0.34	0.47
Debt / EBITDA Ratio	1.00	1.00	1.78	2.67	1.36	1.91
Debt / FCF Ratio	1.35	1.35	2.32	5.70	2.02	2.01
Net Debt / Equity Ratio	0.28	0.28	0.39	0.58	0.29	0.43
Net Debt / EBITDA Ratio	0.91	0.91	1.68	2.60	1.17	1.76
Net Debt / FCF Ratio	1.23	1.23	2.16	5.44	1.72	1.82
Asset Turnover	0.40	0.40	0.35	0.35	0.37	0.32
Inventory Turnover	1.29	1.29	1.42	1.38	1.31	1.08
Quick Ratio	0.59	0.59	0.68	0.42	0.51	0.59
Current Ratio	0.90	0.90	1.05	0.64	0.76	1.00
Return on Equity (ROE)	1.22%	1.22%	10.46%	7.98%	10.61%	12.34%
Return on Assets (ROA)	7.00%	7.00%	4.87%	4.60%	5.58%	4.89%
Return on Invested Capital (ROIC)	16.55%	15.38%	9.38%	8.65%	10.66%	9.15%
Return on Capital Employed (ROCE)	15.60%	15.60%	9.30%	8.50%	12.00%	9.50%
Earnings Yield	0.33%	0.42%	3.52%	2.63%	4.08%	4.84%
FCF Yield	5.83%	7.43%	6.55%	3.92%	6.96%	9.80%
Buyback Yield / Dilution	-0.59%	-0.59%	-6.01%	-9.22%	-0.56%	0.28%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.